Palisade Bio (PALI) Depreciation & Amortization (CF) (2010 - 2023)
Palisade Bio (PALI) posted quarterly Depreciation & Amortization (CF) of $1000.0 for Q3 2025, little changed year-over-year from $1000.0 in Q3 2024, and little changed quarter-over-quarter from $1000.0 in Q2 2025.
Powered by 
Analysis
Palisade Bio (PALI) Depreciation & Amortization (CF) (2010 - 2023) Analysis & Trends
Palisade Bio (PALI) has reported Depreciation & Amortization (CF) for 16 consecutive years, with $1000.0 the latest figure, recorded in Q3 2025.
- In Q3 2025, Depreciation & Amortization (CF) changed 0.0% year-over-year to $1000.0; the TTM figure through Mar 2026 stood at $2000.0 (down 33.33% YoY), while the FY2025 annual figure was $3000.0, changed 0.0% from the prior year.
- Depreciation & Amortization (CF) held at $1000.0 in Q3 2025 per PALI's latest filing, from $1000.0 in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $2000.0 in Q4 2022 and bottomed at $1000.0 in Q1 2021.
- Historically, Depreciation & Amortization (CF) has averaged $1153.8 across 5 years, with a median of $1000.0 in 2021.
- On a YoY basis, Depreciation & Amortization (CF) climbed as much as 103.56% in 2021 and fell as far as 96.56% in 2021.
- Palisade Bio's Depreciation & Amortization (CF) stood at $1000.0 in 2021, then surged by 100.0% to $2000.0 in 2022, then slumped by 50.0% to $1000.0 in 2023, then changed by 0.0% to $1000.0 in 2024, then changed by 0.0% to $1000.0 in 2025.
- Business Quant data shows PALI's Depreciation & Amortization (CF) at $1000.0 in Q3 2025, $1000.0 in Q2 2025, and $1000.0 in Q1 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 56.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 123.70 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 40.52 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Palisade Bio | 440.73 Mn | 315.53 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2023 | 1,000.00 |
| Jun 30, 2023 | 2,000.00 |
| Mar 31, 2023 | 1,000.00 |
| Dec 31, 2022 | 2,000.00 |
| Mar 31, 2022 | 1,000.00 |
| Jun 30, 2021 | 1,000.00 |
| Mar 31, 2021 | 1,000.00 |
| Dec 31, 2020 | 1,000.00 |
| Sep 30, 2020 | 1,000.00 |
| Jun 30, 2020 | -28,078.00 |
| Mar 31, 2020 | 29,078.00 |
| Dec 31, 2019 | 30,124.00 |
| Sep 30, 2019 | 36,584.00 |
| Jun 30, 2019 | 37,330.00 |
| Mar 31, 2019 | 39,821.00 |
| Dec 31, 2018 | 25,339.00 |
| Sep 30, 2018 | 46,152.00 |
| Jun 30, 2018 | 46,938.00 |
| Mar 31, 2018 | 67,374.00 |
| Dec 31, 2017 | 55,619.00 |